Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1985 Mar-Apr;58(2):79–90.

The poliomyelitis story: a scientific hegira.

D M Horstmann
PMCID: PMC2589894  PMID: 2994307

Abstract

There is evidence that paralytic poliomyelitis occurred in ancient times, but it was not recognized as a distinct disease until the eighteenth century and did not come into prominence until the late nineteenth century when epidemics began to appear. Outbreaks of increasing size were reported first in the Scandinavian countries, then in the United States and elsewhere, to the surprise and consternation of the medical profession. Poliovirus was first isolated in 1908, but many years of intensive research were required before the epidemiology and pathogenesis of the disease were sufficiently understood to allow preventive measures to be devised. The road to eventual success was complicated by controversies, setbacks, and tragedies, played out and influenced by many powerful personalities. Today there are two effective vaccines. The disease has been virtually eliminated in countries where they have been used extensively, yet in the developing areas of the world recent "lameness surveys" indicate that the incidence of paralytic poliomyelitis is as high as it was during the peak years in the United States in the early 1950s. The challenge now is to use the available vaccines to extend control to the developing countries and eventually to achieve elimination of the disease worldwide.

Full text

PDF
80

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BODIAN D., PAFFENBARGER R. S., Jr Poliomyelitis infection in households; frequency of viremia and specific antibody response. Am J Hyg. 1954 Jul;60(1):83–98. [PubMed] [Google Scholar]
  2. Bernier R. H. Some observations on poliomyelitis lameness surveys. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S371–S375. doi: 10.1093/clinids/6.supplement_2.s371. [DOI] [PubMed] [Google Scholar]
  3. Enders J. F., Weller T. H., Robbins F. C. Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues. Science. 1949 Jan 28;109(2822):85–87. doi: 10.1126/science.109.2822.85. [DOI] [PubMed] [Google Scholar]
  4. Fox J. P. Eradication of poliomyelitis in the United States: a commentary on the Salk reviews. Rev Infect Dis. 1980 Mar-Apr;2(2):277–281. doi: 10.1093/clinids/2.2.277. [DOI] [PubMed] [Google Scholar]
  5. HORSTMANN D. M., McCOLLUM R. W., MASCOLA A. D. Viremia in human poliomyelitis. J Exp Med. 1954 Apr 1;99(4):355–369. doi: 10.1084/jem.99.4.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HORSTMANN D. M. Poliomyelitis virus in blood of orally infected monkeys and chimpanzees. Proc Soc Exp Biol Med. 1952 Mar;79(3):417–419. doi: 10.3181/00379727-79-19398. [DOI] [PubMed] [Google Scholar]
  7. KOPROWSKI H., JERVIS G. A., NORTON T. W. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am J Hyg. 1952 Jan;55(1):108–124. doi: 10.1093/oxfordjournals.aje.a119499. [DOI] [PubMed] [Google Scholar]
  8. PAUL J. R., MELNICK J. L., BARNETT V. H., GOLDBLUM N. A survey of neutralizing antibodies to poliomyelitis virus in Cairo, Egypt. Am J Hyg. 1952 May;55(3):402–413. doi: 10.1093/oxfordjournals.aje.a119532. [DOI] [PubMed] [Google Scholar]
  9. PAUL J. R., RIORDAN J. T., MELNICK J. L. Antibodies to three different antigenic types of poliomyelitis virus in sera from North Alaskan Eskimos. Am J Hyg. 1951 Sep;54(2):275–285. doi: 10.1093/oxfordjournals.aje.a119485. [DOI] [PubMed] [Google Scholar]
  10. Paul J. R., Trask J. D. THE DETECTION OF POLIOMYELITIS VIRUS IN SO CALLED ABORTIVE TYPES OF THE DISEASE. J Exp Med. 1932 Aug 31;56(3):319–343. doi: 10.1084/jem.56.3.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SALK J. E. Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress. J Am Med Assoc. 1953 Mar 28;151(13):1081–1098. [PubMed] [Google Scholar]
  12. Sabin A. B. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis. 1985 Mar;151(3):420–436. doi: 10.1093/infdis/151.3.420. [DOI] [PubMed] [Google Scholar]
  13. Sabin A. B., Ward R. THE NATURAL HISTORY OF HUMAN POLIOMYELITIS : I. DISTRIBUTION OF VIRUS IN NERVOUS AND NON-NERVOUS TISSUES. J Exp Med. 1941 May 31;73(6):771–793. doi: 10.1084/jem.73.6.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Salk J. One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S444–S450. doi: 10.1093/clinids/6.supplement_2.s444. [DOI] [PubMed] [Google Scholar]
  15. van Wezel A. L., van Steenis G., Hannik C. A., Cohen H. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Dev Biol Stand. 1978;41:159–168. [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES